Kiniksa Pharmaceuticals Ltd Free Cash Flow Generation Index
Kiniksa Pharmaceuticals Ltd free cash flow generation index. Kiniksa Pharmaceuticals Ltd (KNSA) has a Free Cash Flow Generation Index of 0.99x as of June 2026. Free cash flow of $46.80 Million represents 1% of operating cash flow ($47.46 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Kiniksa Pharmaceuticals Ltd (2022–2025)
Free cash flow generation index of Kiniksa Pharmaceuticals Ltd from 2022 to 2025. Historical FCF Generation Index trend for Kiniksa Pharmaceuticals Ltd across 4 annual periods. See KNSA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Kiniksa Pharmaceuticals Ltd Free Cash Flow Generation Index by Year (2022–2025)
Kiniksa Pharmaceuticals Ltd free cash flow generation index by year from 2022 to 2025. Year-by-year Free Cash Flow Generation Index for Kiniksa Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Kiniksa Pharmaceuticals Ltd (KNSA) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▲ +0.0% |
| 2024 | 0.99x | $25.41 Million | $25.69 Million | $277.00K | ▼ -0.1% |
| 2023 | 0.99x | $13.17 Million | $13.30 Million | $130.00K | ▲ +0.8% |
| 2022 | 0.98x | $5.70 Million | $5.81 Million | $105.00K | — |